Trial Profile
To compare the efficacy and safety of Canaglflozin with Sitagliptin in patients with type 2 diabetes mellitus: a retrospective, cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2017
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 24 Oct 2017 New trial record
- 12 Oct 2017 Results published in the Singapore Medical Journal